Innovent Biologics Market Cap

Innovent Biologics has a market cap or net worth of 160.75 billion as of November 25, 2025. Its market cap has increased by 148.14% in one year.

Market Cap

160.75B

Enterprise Value

153.99B

Revenue

12.52B

Ranking

n/a

PE Ratio

126.88

Stock Price

95.30

Market Cap Chart

Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 160.75B, an increase of 767.07%. That is a compound annual growth rate of 35.71%.

Market Cap History

Date	Market Cap	% Change
Nov 25, 2025	160.75B	168.11%
Dec 31, 2024	59.96B	-13.32%
Dec 29, 2023	69.17B	34.57%
Dec 30, 2022	51.40B	-27.14%
Dec 31, 2021	70.55B	-38.71%
Dec 31, 2020	115.10B	243.36%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Oct 31, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	299.58B
Hansoh Pharmaceutical Group Company	243.37B
JD Health International	200.25B
WuXi Biologics	130.46B
Sino Biopharmaceutical	122.63B
Sichuan Kelun-Biotech Biopharmaceutical	104.98B
Akeso	103.63B
Alibaba Health Information Technology	92.34B

Market Cap Rankings